KARABELAS ARGERIS N
SEC CIK 1191229 · EDGAR
BoughtSold
Most active insiders at RGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ciongoli Gregory Austin | Dir | $949.4K | — |
| 2 | PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| 3 | Simpson Curran | CEO, Dir | — | $339.1K |
| 4 | Malzahn Craig | CTO | — | — |
| 5 | Bennett Jean | Dir | — | — |
| 6 | Chan Mitchell | CFO | — | — |
| 7 | Zachary Jennifer | Dir | — | — |
| 8 | Glucksmann Alexandra | Dir | — | — |
| 9 | Fox Allan M. | Dir | — | — |
| 10 | Mills Kenneth T. | Dir | — | — |
| 14 | KARABELAS ARGERIS N | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 17:16 | 2026-05-29 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +9,807 | 28.9K | +51% | $0 |
| D | 2025-06-03 | 2025-05-30 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +7,768 | 19.1K | +69% | $0 |
| DT | 2024-10-02 | 2024-10-01 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | M - OptEx | $3.76 | +10.0K | 21.3K | +89% | +$37.6K |
| DT | 2024-10-02 | 2024-10-01 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | S - Sale+OE | $10.11 | -10.0K | 11.3K | -47% | -$101.1K |
| DT | 2024-09-04 | 2024-09-03 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | M - OptEx | $3.76 | +10.0K | 21.3K | +89% | +$37.6K |
| DMT | 2024-09-04 | 2024-09-03 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | S - Sale+OE | $11.56 | -10.0K | 12.0K | -45% | -$115.6K |
| DMT | 2024-08-05 | 2024-08-01 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | S - Sale+OE | $13.51 | -10.1K | 11.3K | -47% | -$136.5K |
| DMT | 2024-08-05 | 2024-08-01 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | M - OptEx | $3.85 | +10.1K | 21.3K | +90% | +$38.9K |
| DT | 2024-07-30 | 2024-07-29 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | S - Sale+OE | $15.05 | -11.0K | 11.3K | -49% | -$165.6K |
| DT | 2024-07-30 | 2024-07-29 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | M - OptEx | $12.74 | +11.0K | 22.3K | +97% | +$140.1K |
| DT | 2024-07-03 | 2024-07-01 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | S - Sale+OE | $11.27 | -10.0K | 11.3K | -47% | -$112.7K |
| DT | 2024-07-03 | 2024-07-01 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | M - OptEx | $3.76 | +10.0K | 21.3K | +89% | +$37.6K |
| D | 2024-06-04 | 2024-05-31 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +4,790 | 11.3K | +74% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| 2022-06-28 | 2022-06-24 | BHC | Bausch Health Companies Inc. | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +34.4K | 123.7K | +38% | $0 | |
| D | 2022-06-07 | 2022-06-03 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations